TradingMarkets’ 11 Stocks You Need To Know About Today

Best Buy
(
BBY |
Quote |
Chart |
News |
PowerRating)
reported Q4 of $1.55, in-line $9.227 billion, also
in line. The report was delayed.

Taser
(
TASR |
Quote |
Chart |
News |
PowerRating)
forecast weaker-than-expected sales; shares are
trading down pre-open. The company now expects sales of $10 million in Q1 vs.
$13.6 million previously forecast. The company blames significant adverse
publicity.”

Biogen
(
BIIB |
Quote |
Chart |
News |
PowerRating)
told investors not to rely on recent guidance issue
on February 7, before the company suspended sales of Tysabri.

Palmsource
(
PRSC |
Quote |
Chart |
News |
PowerRating)
reported a loss for Q3 on lighter sales but
forecast a smaller loss than previously expected.

Medicis
(
MRX |
Quote |
Chart |
News |
PowerRating)
and Allergan
(
AGN |
Quote |
Chart |
News |
PowerRating)
were the subject of a
positive article in Barron’s Online.

Cognos
(
COGN |
Quote |
Chart |
News |
PowerRating)
beat estimates but guided lower for Q1.Separately,
the company sign a multi-year agreement with Amazon.com. UBS upgraded the stock
to ‘buy’ from ‘neutral.’

Carl Icahn plans to increase his stake in Hollywood Entertainment
(
HLYW |
Quote |
Chart |
News |
PowerRating)
to 10.84%.

Seprecor
(
SEPR |
Quote |
Chart |
News |
PowerRating)
expects to begin selling its sleeping pill
Lunesta in a few days.

Red Hat’s
(
RHAT |
Quote |
Chart |
News |
PowerRating)
sales more than doubled and increased its stock
buyback program.

Alopharma
(
ALOP |
Quote |
Chart |
News |
PowerRating)
missed by 0.04 and guided lower.